Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 5
2012 2
2013 5
2014 3
2015 4
2016 4
2017 4
2018 3
2019 1
2021 3
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Patient-derived parathyroid organoids as a tracer and drug-screening application model.
Noltes ME, Sondorp LHJ, Kracht L, Antunes IF, Wardenaar R, Kelder W, Kemper A, Szymanski W, Zandee WT, Jansen L, Brouwers AH, Coppes RP, Kruijff S. Noltes ME, et al. Among authors: jansen l. Stem Cell Reports. 2022 Nov 8;17(11):2518-2530. doi: 10.1016/j.stemcr.2022.09.015. Epub 2022 Oct 27. Stem Cell Reports. 2022. PMID: 36306782 Free PMC article.
Evolution in sentinel lymph node biopsy in breast cancer.
Qiu SQ, Zhang GJ, Jansen L, de Vries J, Schröder CP, de Vries EGE, van Dam GM. Qiu SQ, et al. Among authors: jansen l. Crit Rev Oncol Hematol. 2018 Mar;123:83-94. doi: 10.1016/j.critrevonc.2017.09.010. Epub 2017 Sep 20. Crit Rev Oncol Hematol. 2018. PMID: 29482783 Review.
Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.
Noltes ME, Kruijff S, Appelman APA, Jansen L, Zandee WT, Links TP, van Hemel BM, Schouw HM, Dierckx RAJO, Francken AB, Kelder W, van der Hoorn A, Brouwers AH. Noltes ME, et al. Among authors: jansen l. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1050-1059. doi: 10.1007/s00259-023-06488-7. Epub 2023 Nov 17. Eur J Nucl Med Mol Imaging. 2024. PMID: 37975887 Free PMC article.
Validity of the BreastConservation! nomogram evaluated.
Pleijhuis RG, Kwast AB, Jansen L, de Vries J, Wiggers T, Siesling S, van Dam GM. Pleijhuis RG, et al. Among authors: jansen l. Breast. 2015 Oct;24(5):540-2. doi: 10.1016/j.breast.2015.07.001. Epub 2015 Sep 4. Breast. 2015. PMID: 26346587 No abstract available.
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer.
Metman MJH, Jonker PKC, Sondorp LHJ, van Hemel BM, Sywak MS, Gill AJ, Jansen L, van Diest PJ, van Ginhoven TM, Löwik CWGM, Nguyen AH, Robinson DJ, van Dam GM, Links TP, Coppes RP, Fehrmann RSN, Kruijff S. Metman MJH, et al. Among authors: jansen l. Eur J Nucl Med Mol Imaging. 2023 Nov 29. doi: 10.1007/s00259-023-06525-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2023. PMID: 38017325
89Zr-bevacizumab PET imaging in primary breast cancer.
Gaykema SB, Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP. Gaykema SB, et al. Among authors: jansen l. J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651946 Free article. Clinical Trial.
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.
Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Koller M, et al. Among authors: jansen l. Nat Commun. 2018 Sep 18;9(1):3739. doi: 10.1038/s41467-018-05727-y. Nat Commun. 2018. PMID: 30228269 Free PMC article. Clinical Trial.
38 results